A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors

Human Gene Therapy

Volumn 11, Issue 14, 2000, Pages 2009-2024

  Hernandez Alcoceba, R ^a   Pihalja, M ^a   Wicha, M S ^a   Clarke, M F ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR; TAMOXIFEN;

ADENOVIRUS; ADOLESCENT; APOPTOSIS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; EXPRESSION VECTOR; GENE ACTIVATION; GENE DELETION; GENE THERAPY; GENETIC COMPLEMENTATION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; MODULATION; MOUSE; NONHUMAN; NUDE MOUSE; PROMOTER REGION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ADENOVIRUS E4 PROTEINS; ANIMALS; BREAST NEOPLASMS; CELL DEATH; ESTROGENS; FEMALE; GENE DELETION; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; HUMANS; LUCIFERASES; MICE; MICE, INBRED BALB C; MICE, NUDE; MODELS, GENETIC; PLASMIDS; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; TAMOXIFEN; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5; MUS MUSCULUS;

EID: 0034692458     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050143435     Document Type: Article

References (42)

1. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence
2. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
3. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing
4. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
5. Regulated gene expression systems
6. A recombinant bcl-xs adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells
7. Cancer gene therapy: Connecting basic research with clinical inquiry
8. Bclx-s gene therapy induces apoptosis of human mammary tumors in nude mice
9. Determinants of ligand specificity of estrogen receptor-α: Estrogen versus androgen discrimination
10. Adenovirus early region 4 is required for efficient virus particle assembly
11. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
12. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy
13. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff
14. p53 Cell death/apoptosis is required for a productive adenovirus infection
15. A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma
16. A method of limited replication for the efficient in vivo delivery of adenovirus to cancer cells
17. Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: The importance of the E1b-55kD gene
18. A simplified system for generating recombinant adenoviruses
19. ONYX-015, and E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
20. Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy
21. Structure of the human oestrogen-responsive gene pS2
22. ONYX-015: Clinical data are encouraging
23. Transcription activation by the adenovirus E1a protein
24. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted
25. The early region 4 orf4 protein of human adenovirus type 5 induces p53-independent death by apoptosis
26. Human estrogen receptor ligand activity inversion mutants: Receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens
27. Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus
28. Vector development for cancer gene therapy
29. The pS2/TFF1 trefoil factor, from basic research to clinical applications
30. The pS2 gene, mRNA and protein: A potential marker for human breast cancer
31. Gene therapy for cancer: What have we done and where are we going?
32. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells
33. Adenoviridae: The viruses and their replication
34. Modulation of the specificity and activity of a cellular promoter in an adenoviral vector
35. Adenovirus type 5 E4 open reading frame 4 protein induces apoptosis in transformed cells
36. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
37. Reliability of estrogen receptors in predicting response to antiestrogens
38. Insulation of a conditionally expressed transgene in an adenoviral vector
39. Serial analysis of gene expression
40. Cancer gene therapy: Hard lessons and new courses
41. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpex simplex virus-thymidine kinase
42. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of Calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy